Amifampridine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Amifampridine. Educational only — not medical advice.
Labeled uses
FIRDAPSE ® is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older.
Source: FDA labeling via NIH DailyMed (set f015fe60…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.